Oral drug dosage forms administered to hospitalized children: Analysis of 117,665 oral administrations in a French paediatric hospital over a 1-year period

International Journal of Pharmaceutics
A LajoinieB Kassai

Abstract

Selecting the most appropriate dosage form, that ensures safe administration and adherence of medications, is a major issue for children. Marketed drugs, however, have rarely been tested for their use in children. There is a need for more data on drug formulations administered to children to identify unmet needs, and drive future paediatric research. We observed, over a 12-month follow-up, 117,665 oral drug administrations to 1998 hospitalized children. Nine-tenths belonged to five Anatomical Therapeutic Chemical classes: Alimentary tract & metabolism, Nervous system, Cardiovascular system, Anti-infectives for systemic use and Blood & blood forming organs, one third of drug doses administered to school-age children and adolescents were liquids, and extemporaneous capsules were commonly used in younger children. Our study shows that despite the advantages of solid dosage forms and recent evidence from randomized controlled trials showing their acceptability in infants, they are seldom used in paediatric practice.

References

Jul 1, 1975·The Journal of Pediatrics·M E MattarS J Yaffe
Aug 1, 1995·Journal of the Royal Society of Health·S A al-ShammariM J al-Yamani
Jan 1, 1995·Infection·K SunakawaR Fujii
May 23, 2001·Archives of Disease in Childhood·H BauchnerJ Chessare
Jul 27, 2001·Tropical Medicine & International Health : TM & IH·E K AnsahD B Evans
Feb 18, 2004·The Annals of Pharmacotherapy·Glen T SchumockRichard K Lewis
Jun 14, 2005·British Journal of Clinical Pharmacology·Tony Nunn, Julie Williams
Jun 28, 2005·International Journal of Pharmaceutics·Joseph F Standing, Catherine Tuleu
Nov 29, 2007·Scandinavian Journal of Primary Health Care·Allan BuusmanBeth Elverdam
Oct 14, 2008·International Journal of Pharmaceutics·Anne CramUNKNOWN European Paediatric Formulation Initiative (EuPFI)
Jan 28, 2009·Pediatrics·Sarah A ThomsonAlastair G Sutcliffe
Jan 19, 2012·Archives of Disease in Childhood·Natalie SpomerJoerg Breitkreutz
Aug 21, 2012·Basic & Clinical Pharmacology & Toxicology·Michael D LarsenJesper Hallas
Jul 16, 2013·Archives of Disease in Childhood·Diana A van Riet-NalesCatharine M A Rademaker
Jun 27, 2014·British Journal of Clinical Pharmacology·Audrey LajoinieDavid Terry
Jan 21, 2015·International Journal of Pharmaceutics·Rebecca VenablesJohn Marriott
Mar 5, 2015·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Marta Slavkova, Jörg Breitkreutz
Apr 17, 2015·European Journal of Clinical Pharmacology·Audrey LajoinieUNKNOWN EREMI Group
May 12, 2015·International Journal of Pharmaceutics·Hannah BatchelorUNKNOWN European Paediatric Formulation Initiative (EuPFI)
Jul 6, 2015·International Journal of Pharmaceutics·Diana A van Riet-NalesCarin M A Rademaker
Jul 16, 2015·International Journal of Clinical Pharmacy·Rebecca VenablesJohn Marriott

❮ Previous
Next ❯

Citations

Aug 6, 2016·International Journal of Pharmaceutics·A C WalchUNKNOWN EREMI Group
Feb 27, 2017·Archives of Disease in Childhood·Sara Arenas-LópezCatherine Tuleu
Dec 6, 2019·Tropical Medicine & International Health : TM & IH·Brunna Soares Rodrigues CostaLourena Mafra Veríssimo
Jun 9, 2016·AAPS PharmSciTech·Diana A Van Riet-NalesAlfred F A M Schobben
Dec 12, 2019·Journal for Specialists in Pediatric Nursing : JSPN·Min ZhangLing Gao

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Clinical Pharmacy
Adriana Cristina de Souza GonçalvesMaria Cândida Ferrarez Bouzada
International Journal of Pharmaceutics
Joseph F Standing, Catherine Tuleu
Clinical Therapeutics
M C Nahata, Loyd V Allen
Schizophrenia Bulletin
William Carpenter
© 2021 Meta ULC. All rights reserved